![Liat Flaishon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Liat Flaishon is the founder of CyToD Ltd. which was founded in 2008.
She held the title of Inventor from 2008 to 2009.
Dr. Flaishon's former jobs include Director-Drug Safety Risk Management Plans at Teva Pharmaceutical Industries Ltd. from 2007 to 2011, Director-Business Development at Pluri, Inc., and VP-Business Development & Clinical Affairs at Intec Pharma Ltd. Dr. Flaishon's education includes a doctorate degree from Weizmann Institute of Science and a doctorate degree from Sackler School of Medicine.
Ehemalige bekannte Positionen von Liat Flaishon
| Unternehmen | Position | Ende |
|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01.01.2011 |
| PLURI INC. | Corporate Officer/Principal | - |
Intec Pharma Ltd.
 Intec Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products to treat neurodegenerative diseases | Technik-/Wissenschafts-/F&E-Leiter | - |
CyToD Ltd.
 CyToD Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic approach to treat such chronic asthma and rheumatoid arthritis | Gründer | - |
Ausbildung von Liat Flaishon
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
51
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Pluri, Inc.
 Pluri, Inc. BiotechnologyHealth Technology Develops placenta-based cell therapy products for the treatment of muscle trauma and hematological disorders, radiation damage and inflammation | Health Technology |
Weizmann Institute of Science
 Weizmann Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CyToD Ltd.
CyToD Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic approach to treat such chronic asthma and rheumatoid arthritis | Health Technology |
Intec Pharma Ltd.
Intec Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products to treat neurodegenerative diseases | Health Technology |
Sackler School of Medicine
 Sackler School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
